Pfizer Inc (WBO:PFE)
€ 24.955 -0.445 (-1.75%) Market Cap: 140.28 Bil Enterprise Value: 192.77 Bil PE Ratio: 36.11 PB Ratio: 1.64 GF Score: 74/100

Pfizer Inc at Cowen Health Care Conference Transcript

Mar 07, 2023 / 03:30PM GMT
Release Date Price: €38.02 (-1.14%)
Stephen Michael Scala
TD Cowen, Research Division - MD & Senior Research Analyst

(technical difficulty)

come back again this year. Representing the company is Angela Hwang, who's Chief Commercial Officer, President, Global Biopharmaceutical Business; Lisa Anderson, who is Senior Vice President and CSO of the Vaccine Research and Development operation; and then Rodrigo Puga, who is U.S. Commercial and Global Business Lead for Internal Medicine. So I'd like to turn it over to Chris Stevo, who is also here on stage to read the disclaimer.

Christopher J. Stevo
Pfizer Inc. - Senior VP & Chief IR Officer

So my favorite part, we're going to be making forward-looking statements during today's call. Any statements we make are valid only as of today, and we undertake no obligation to update them in the future. And if you have more questions on our forward-looking statements, you can see our SEC filings under Forms 10-Q and 10-K under the sections on Forward-looking Statements.

So with that, let me turn it over to my colleagues. Thanks.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot